At the pharmacy counter, patients usually get the easiest assignment in American healthcare: pay whatever the screen says. Behind that number lies a chain of contracts, rebates, fees, and reimbursements that can make buying medicine feel like hiring a magician…
Massive companies that oversee prescriptions for tens of millions of Americans will soon be required to provide detailed information on how much money they make from drugmakers, under a new regulation released Thursday by the Trump administration. Under the Labor…
Drs. Robert Malone and Jill Glasspool Malone · Washington, DC · October 27, 2026 If you raise cows and a feed mill sells you a contaminated batch, you can take the mill to court. The same holds for the dealer who sold you a…
WASHINGTON (October 27, 2026) — The Council for Innovation Promotion (C4IP) today raised concerns about potential unintended consequences for American biotechnology innovation under the U.S. Treasury Department’s proposed efforts to protect national security through restrictions on certain outbound investments. C4IP is concerned that the proposal’s…
The new Channel 4 documentary The Experiment asks a disturbing question – can ordinary people be persuaded to accept Nazi-era ideas about disabled people if they were presented as compassionate, progressive and cost effective? The results should make us take a good…
Republicans and Democrats, both patients and politicians, seem united in their disdain for the healthcare companies known as pharmacy benefit managers. Tennessee and Arkansas are regulating now them. Thanks to our sponsors – Become a Sponsor Republicans and Democrats find a…
Pharma sees a potential catch in Washington’s latest effort to curb China’s biotech ambitions Happy Friday, and welcome to Health Brief. Calley Means, a key member of the Make America Healthy Again movement, announced he would be leaving the Trump…
One of the components is an update to Medicare’s drug pricing model, basing pricing on the average sales price across a number of nations. The rule, due to take effect on Jan. 1, “would untether Medicare pricing from the statute and…
A new, bipartisan Senate bill could help employers and their benefits advisors push down the cost of covering specialty drugs and mail-order drugs. Sen. Bill Cassidy, R-La., and Sen. Mark Warner, D-Va., have joined to introduce the Ensuring Accurate Payments…
Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy. 10/23/2026 12:00 PM EDT TREASURY EYES CHINA BIOTECH DEALS — The Treasury Department proposed new rules Thursday to curb U.S. investment in Chinese biotechnology — just as American drugmakers…
Coverage access, affordability, and reforms to lower costs.
An article joins this feed when it matches these terms. Each one is also a search of its own.